Minimum stable structure of the receptor for advanced glycation end product possesses multi ligand binding ability

Biochemical and Biophysical Research Communications

Volumn 386, Issue 1, 2009, Pages 130-134

  Kumano Kuramochi, M ^a   Ohnishi Kameyama, M ^a   Xie, Q ^a   Niimi, S ^a   Kubota, F ^a   Komba, S ^a   Machida, S ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

AGE; Diabetic complications; Ligand binding; RAGE; Recognition devise

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; PROTEINASE;

ARTICLE; LIGAND BINDING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN STRUCTURE; SENSITIVITY ANALYSIS;

AMINO ACID SEQUENCE; FACTOR XA; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIGANDS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, IMMUNOLOGIC; THROMBIN;

EID: 67649236113     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.05.142     Document Type: Article

References (18)

1. Wautier J.L., and Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ. Res. 95 (2004) 233-238
2. Bierhaus A., Hofmann M.A., Ziegler R., and Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc. Res. 37 (1998) 586-600
3. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001) 813-820
4. Schleicher E.D., Wagner E., and Nerlich A.G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99 (1997) 457-468
5. Schmidt A.M., Hori O., Chen J.X., Li J.F., Crandall J., Zhang J., Cao R., Yan S.D., Brett J., and Stern D. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. a potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96 (1995) 1395-1403
6. Schmidt A.M., Yan S.D., Yan S.F., and Stern D.M. The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498 (2000) 99-111
7. Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., and Shaw A. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem. 267 (1992) 14998-15004
8. Ostendorp T., Weibel M., Leclerc E., Kleinert P., Kroneck P.M., Heizmann C.W., and Fritz G. Expression and purification of the soluble isoform of human receptor for advanced glycation end products (sRAGE) from Pichia pastoris. Biochem. Biophys. Res. Commun. 347 (2006) 4-11
9. Xie J., Burz D.S., He W., Bronstein I.B., Lednev I., and Shekhtman A. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J. Biol. Chem. 282 (2007) 4218-4231
10. Wilton R., Yousef M.A., Saxena P., Szpunar M., and Stevens F.J. Expression and purification of recombinant human receptor for advanced glycation endproducts in Escherichia coli. Protein Expr. Purif. 47 (2006) 25-35
11. Kumano-Kuramochi M., Xie Q., Sakakibara Y., Niimi S., Sekizawa K., Komba S., and Machida S. Expression and characterization of recombinant C-terminal biotinylated extracellular domain of human receptor for advanced glycation end products (hsRAGE) in Escherichia coli. J. Biochem. 143 (2008) 229-236
12. Dattilo B.M., Fritz G., Leclerc E., Kooi C.W., Heizmann C.W., and Chazin W.J. The extracellular region of the receptor for advanced glycation end products is composed of two independent structural units. Biochemistry 46 (2007) 6957-6970
13. Xie J., Reverdatto S., Frolov A., Hoffmann R., Burz D.S., and Shekhtman A. Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J. Biol. Chem. 283 (2008) 27255-27269
14. Matsumoto S., Yoshida T., Murata H., Harada S., Fujita N., Nakamura S., Yamamoto Y., Watanabe T., Yonekura H., Yamamoto H., Ohkubo T., and Kobayashi Y. Solution structure of the variable-type domain of the receptor for advanced glycation end products: new insight into AGE-RAGE interaction. Biochemistry 47 (2008) 12299-12311
15. Hudson B.I., Bucciarelli L.G., Wendt T., Sakaguchi T., Lalla E., Qu W., Lu Y., Lee L., Stern D.M., Naka Y., Ramasamy R., Yan S.D., Yan S.F., D'Agati V., and Schmidt A.M. Blockade of receptor for advanced glycation end products: a new target for therapeutic intervention in diabetic complications and inflammatory disorders. Arch. Biochem. Biophys. 419 (2003) 80-88
16. Beckett D., Kovaleva E., and Schatz P.J. A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation. Protein Sci. 8 (1999) 921-929
17. Valencia J.V., Weldon S.C., Quinn D., Kiers G.H., DeGroot J., TeKoppele J.M., and Hughes T.E. Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics. Anal. Biochem. 324 (2004) 68-78
18. Kislinger T., Fu C., Huber B., Qu W., Taguchi A., Du Yan S., Hofmann M., Yan S.F., Pischetsrieder M., Stern D., and Schmidt A.M. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 274 (1999) 31740-31749